|
DDX42 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.604930E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.779830E-02 |
| Normal-vs-Stage2 |
4.918400E-01 |
| Normal-vs-Stage3 |
1.107390E-01 |
| Normal-vs-Stage4 |
2.113800E-01 |
| Stage1-vs-Stage2 |
4.854000E-01 |
| Stage1-vs-Stage3 |
8.672600E-01 |
| Stage1-vs-Stage4 |
4.127800E-01 |
| Stage2-vs-Stage3 |
4.935400E-01 |
| Stage2-vs-Stage4 |
3.120400E-01 |
| Stage3-vs-Stage4 |
4.539400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.404020E-03 |
| Normal-vs-AfricanAmerican |
1.596810E-01 |
| Normal-vs-Asian |
2.358700E-03 |
| Caucasian-vs-AfricanAmerican |
1.150240E-01 |
| Caucasian-vs-Asian |
4.423000E-01 |
| AfricanAmerican-vs-Asian |
9.604500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.885940E-02 |
| Normal-vs-Female |
8.02050000000554E-05 |
| Male-vs-Female |
2.271800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.914300E-02 |
| Normal-vs-Extreme_Weight |
7.771600E-02 |
| Normal-vs-Obese |
4.258500E-02 |
| Normal-vs-Extreme_Obese |
7.789600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.855800E-01 |
| Normal_Weight-vs-Obese |
4.111400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.585600E-02 |
| Extreme_Weight-vs-Obese |
7.346200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.078200E-01 |
| Obese-vs-Extreme_Obese |
2.124200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.043370E-04 |
| Normal-vs-Age(41-60Yrs) |
3.631700E-04 |
| Normal-vs-Age(61-80Yrs) |
7.986100E-02 |
| Normal-vs-Age(81-100Yrs) |
4.836400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.815600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.540500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.154800E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.078400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.493800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.726000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.804600E-04 |
| Normal-VS-Type2 PRCC |
4.961600E-01 |
| Normal-VS-KIRP CIMP |
3.575900E-03 |
| Normal-VS-Unclassified PRCC |
7.654200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.232100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.311600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.033800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.555850E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.031600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.887600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.270800E-01 |
| Normal-vs-N1 |
1.333840E-02 |
| Normal-vs-N2 |
3.181400E-01 |
| N0-vs-N1 |
2.372500E-02 |
| N0-vs-N2 |
1.843250E-01 |
| N1-vs-N2 |
6.901400E-01 |
|
|
